Adjemout Mathieu, Nisar Samia, Escandell Amélie, Torres Romain, Torres Magali, Nguyen Huu Hong Thu, Thiam Alassane, Manosalva Iris, Mbengue Babacar, Dieye Alioune, Adoue Véronique, Spicuglia Salvatore, Rihet Pascal, Marquet Sandrine
Aix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Infinity, Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, Inserm U1291, CNRS U5051 Toulouse, France.
Cell Genom. 2025 Jul 9;5(7):100889. doi: 10.1016/j.xgen.2025.100889. Epub 2025 May 28.
Regulation of gene expression has recently been complicated by identifying Epromoters, a subset of promoters with enhancer function. Here, we uncovered a dual cis-regulatory element, "ESpromoter," exhibiting both enhancer and silencer function as a regulator of the nearby genes ATP2B4 and LAX1 in single human T cells. Through an integrative approach, we pinpointed functional rs11240391, a severe malaria-risk variant that escapes detection in genome-wide association studies, challenging conventional strategies for identifying causal variants. CRISPR-modified cells demonstrated the regulatory effect of ESpromoter and rs11240391 on LAX1 expression and T cell activation. Furthermore, our findings revealed an epistatic interaction between ESpromoter SNPs and rs11240391, impacting severe malaria susceptibility by further reducing LAX1 expression. This groundbreaking discovery challenges the conventional enhancer-silencer dichotomy. It highlights the sophistication of transcriptional regulation and argues for an integrated approach combining genetics, epigenetics, and genomics to identify new therapeutic targets for complex diseases.
基因表达的调控最近因发现E启动子(具有增强子功能的启动子子集)而变得复杂。在这里,我们发现了一种双重顺式调控元件“ES启动子”,它在单个人类T细胞中作为附近基因ATP2B4和LAX1的调节因子,兼具增强子和沉默子功能。通过综合方法,我们确定了功能性rs11240391,这是一种严重疟疾风险变异体,在全基因组关联研究中未被发现,对识别因果变异的传统策略提出了挑战。经CRISPR修饰的细胞证明了ES启动子和rs11240391对LAX1表达和T细胞活化的调节作用。此外,我们的研究结果揭示了ES启动子单核苷酸多态性与rs11240391之间的上位性相互作用,通过进一步降低LAX1表达影响严重疟疾易感性。这一开创性发现挑战了传统的增强子 - 沉默子二分法。它突出了转录调控的复杂性,并主张采用遗传学、表观遗传学和基因组学相结合的综合方法来识别复杂疾病的新治疗靶点。